Senior insider sale
See Remarks at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$18.64M
266.10K shares
KUMAR NEIL plans to sell 266.10K shares of BRIDGEBIO PHARMA, INC. valued at approximately $18.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/16/2026 | Restricted Stock Units N/A | 26.10K | — |
| Total | 26.10K | ||
Completed
Units to sell
20K
Market value
$1.34M
Units to sell
20K
Market value
$1.34M
Units to sell
20K
Market value
$1.36M
Units to sell
20K
Market value
$1.36M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.38M
Units to sell
20K
Market value
$1.38M
Units to sell
20K
Market value
$1.37M
Units to sell
20K
Market value
$1.37M
Planned — Approximate Date
Units to sell
26.10K
Market value
$1.78M
Units
266.10K
Value
$18.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/8/2026 | 20K | $1.34M | — | Completed |
5/8/2026 | 20K | $1.34M | — | Completed |
5/7/2026 | 20K | $1.36M | — | Completed |
5/7/2026 | 20K | $1.36M | — | Completed |
4/10/2026 | 20K | $1.49M | — | Completed |
4/10/2026 | 20K | $1.49M | — | Completed |
4/9/2026 | 20K | $1.49M | — | Completed |
4/9/2026 | 20K | $1.49M | — | Completed |
3/13/2026 | 20K | $1.38M | — | Completed |
3/13/2026 | 20K | $1.38M | — | Completed |
3/12/2026 | 20K | $1.37M | — | Completed |
3/12/2026 | 20K | $1.37M | — | Completed |
| Planned — Approximate Date | ||||
5/21/2026 | 26.10K | $1.78M | NASDAQ | Planned |
| Total | 266.10K | $18.64M | ||